SplA-F1 |
5′-ATGAGGAATATGGGCTCCG-3′
|
sequencing |
SplA-R1 |
5′-CTGTTTTTTCGTTAAGCATGGTT-3′
|
|
SplA-F2 |
5′-ACTATCAGCAAATCGTTATTGAAGG-3′
|
|
SplA-R2 |
5′-TCAACTGTTGTTGCACCGG-3′
|
|
SplA-F3 |
5′-TATTAAACCTGGAAAAGTAGATGTCC-3′
|
|
SplA-R3 |
5′-TTAAAGGTTTTTAACAAGATTACCAGC-3′
|
|
SplA-F4 |
5′-GGTTAGCCAATATTGAAGCTCTG-3′
|
|
SplA-R4 |
5′-AATCCGCAGAACCTTTAGCA-3′
|
|
SplA-F5 |
5′-AAGATTTAATTGAAACTCTTAATGCAG-3′
|
|
SplA-R5 |
5′-TCGGTACTGCAGAAAACTTTG-3′
|
|
SplA-F |
5′-ATATGGGCTCCGCTATTTCC-3′
|
screening |
SplA-R |
5′-AATCCGCAGAACCTTTAGCA-3′
|
|
Slp773_NcoI-for |
5′-aatcaCCATGGCGAGGAATATGGGCTCCGCTATTTCC-3′
|
recombinant production |
Slp773_XhoI-re |
5′-aatcaCTCGAGTTAAAGGTTTTTAACAAGATTACCAG-3′
|
|
IBS_splA_101 |
5′-AAAAAAGCTTATAATTATCCTTAATAGCCCTGGAAGTGCGCCCAGATAGGGTG-3′
|
splA knockout |
EBS1d_splA_101 |
5-′CAGATTGTACAAATGTGGTGATAACAGATAAGTCCTGGAAACTAACTTACCTTTCTTTGT-3′
|
|
EBS2_splA_101 |
5′-TGAACGCAAGTTTCTAATTTCGGTTGCTATCCGATAGAGGAAAGTGTCT-3′
|
|